cridanimod
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02064725)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Progesterone receptorACTIVATOR
PGR activator
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)Cn1c2ccccc2c(=O)c2ccccc21- Mol. weight
- 253.26 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1569545 ↗
Also known as
- cridanimod
- cridanimod
- cridanimod
- cridanimod
- cridanimod
- neovir
- oxodihydroacridinylacetate sodium
- sodium cridanimod
- sodium cridanimod
- sodium cridanimod
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02064725 | Phase 2 | Sep 1, 2014 | Kevelt AS, Pharmasyntez |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kevelt AS | For profit | 1 | 1 | 1 | 2014 |
| Pharmasyntez | For profit | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1